Determining the ICD-10-PCS Code
Coding Example 6
Let's find a procedure code from Section X, New Technology. Section X, New Technology codes are standalone codes used for new technologies.
Procedure: Introduction of cefiderocol anti-infective into central vein, percutaneous approach, new technology group 6
Click the Index tab to find the first 3 values of the code. Then, click the Table XW0 tab to see the value choices for characters 4-7 of the code. Click the Character Section Table tab to see the value for each character of the code. Last, click the Explanation tab for a full description of each character in the code.
Step 1: Locate the main term entry in the Index. Cefiderocol Anti-infective is the main term, and the first 3 values of the code are XW0. The name of the New Technology Device, Substance, or Technology is a sub term. All codes available in Section X are in the Index under the main term New Technology.
Cefiderocol Anti-infective XW0
Step 2: Locate Table XW0, which shows the possible value choices for the last 4 characters of the code. You need all 7 characters to complete the code. New Technology codes are displayed with separate tables for each root operation and body system, like all other ICD-10-PCS tables.
| Body Part | Approach | Device / Substance / Technology | Qualifier |
|---|---|---|---|
4 Central Vein | 3 Percutaneous | 5 Ceftobiprol Medocaril Anti-infective | A New Technology Group 10 |
4 Central Vein | 3 Percutaneous | 6 Lefamulin Anti-infetive | 6 New Technology Group 6 |
4 Central Vein | 3 Percutaneous | 6 Terlipressin | 7 New Technology Group 7 |
4 Central Vein | 3 Percutaneous | 6 Afamitresgene Autoleucel Immunotherapy | 8 New Technology Group 8 |
4 Central Vein | 3 Percutaneous | 7 Coagulation Factor Xa, Inactivated | 2 New Technology Group 2 |
4 Central Vein | 3 Percutaneous | 7 Trilaciclib | 7 New Technology Group 7 |
4 Central Vein | 3 Percutaneous | 7 Tabelcleucel Immunotherapy | 8 New Technology Group 8 |
4 Central Vein | 3 Percutaneous | 8 Lurbinectedin | 7 New Technology Group 7 |
4 Central Vein | 3 Percutaneous | 8 Treosulfan | 8 New Technology Group 8 |
4 Central Vein | 3 Percutaneous | 8 Obecabtagene Autoleucel | A New Technology Group 10 |
4 Central Vein | 3 Percutaneous | 9 Ceflozane/Tazobactam Anti-infective | 6 New Technology Group 6 |
4 Central Vein | 3 Percutaneous | 9 Inebilizumab-cdon | 8 New Technology Group 8 |
4 Central Vein | 3 Percutaneous | 9 Odronextamab Antineoplastic | A New Technology Group 10 |
4 Central Vein | 3 Percutaneous | A Cefidericaol Anti-infective | 6 New Technology Group 6 |
4 Central Vein | 3 Percutaneous | A Ciltacabtagene Autleucel | 7 New Technology Group 7 |
4 Central Vein | 3 Percutaneous | B Cytarabine and Daunorubicin Liposome Antineoplastic | 3 New Technology Group 3 |
4 Central Vein | 3 Percutaneous | B Omadacycline Anti-infective | 6 New Technology Group 6 |
4 Central Vein | 3 Percutaneous | B Amivantamab Monoclonal Antibody | 7 New Technology Group 7 |
This table shows the correct value for each character of the code. Hover your mouse over each column to see how we selected each value.
| Character 1 Section | Character 2 Body System | Character 3 Root Operation | Character 4 Body Part | Character 5 Approach | Character 6 Device | Character 7 Qualifier |
|---|---|---|---|---|---|---|
| New Technology | Anatomical Regions | Introduction | Central Vein | Percutaneous | Cefiderocol | New Technology Group 6 |
| X | W | 0 | 4 | 3 | A | 6 |
Code Assignment for this Procedure: XW043A6
Character 1: Section
The first character identifies the broad procedure category or section where the code is found. In this example, X is the New Technology section in the first character.
Character 2: Body system
The second character identifies the body system. Body system refers to the general physiological system or anatomical region where the health care provider performed the procedure. Examples of body systems include Tendons, Lower Arteries, Central Nervous System, and Cranial Nerves. In this example, W is the body system Anatomical Regions in the second character.
Character 3: Root operation
The third character identifies the root operation or objective of the procedure. Examples of root operations are Excision, Bypass, and Drainage. In this example, 0 is the root operation Introduction in the third character.
Character 4: Body part
The fourth character identifies the body part or specific anatomical site where the health care provider performed the procedure. The body system, which is the second character, provides only a general idea of the procedure site. The body part and body system values together give a precise description of the procedure site. Examples of body parts are Lower Arm and Wrist, Right; Kidney; and Tonsils. In this example, the body part value 4 is Central Vein in the fourth character. When W, Anatomical Regions, appears in the second character and 4, Central Vein, appears in the fourth character, they're Anatomical Regions, Central Vein.
Character 5: Approach
The fifth character identifies the approach, or technique the health care provider used to reach the procedure site. The Medical and Surgical section includes 8 values to define the approach. Examples of approaches include open and percutaneous endoscopic. In this example, 3 is Percutaneous approach in the fifth character.
Character 6: Device
The sixth character identifies the device. Some procedures need a device left in place at the end of the procedure. Device values fall into these 4 basic categories:
- Grafts and Prostheses
- Implants
- Simple or Mechanical Appliances
- Electronic Appliances
In this example, the value A is Cefiderocol Anti-Infective in the sixth character.
Character 7: Qualifier
The seventh character identifies a qualifier, which specifies an added attribute of the procedure, if applicable. Examples of qualifiers include diagnostic and stereotactic. Qualifier choices vary depending on the previous values chosen. In this example, 6 is New Technology Group 6 in the seventh character.
The Section X code fully identifies administration of cefiderocol anti-infective. You don’t need to include any more codes, including separate codes from Table 3E0 in the Administration section.